Dr. Patil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 502-526-6835Fax+1 215-456-7926
Education & Training
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2010 - 2013
- Seth G.S. Medical CollegeClass of 2008
Certifications & Licensure
- NY State Medical License 2023 - 2025
- OH State Medical License 2013 - 2024
- PA State Medical License 2010 - 2013
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 40 citationsComutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, Alissa J Cooper, Neal S Akhave
Cancer Discovery. 2023-07-07 - 21 citationsImpact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastasesAdam Lauko, Rupesh Kotecha, Addison Barnett, Hong Li, Vineeth Tatineni
Scientific Reports. 2021-09-13 - 21 citationsPerioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer.Bharathi Muthusamy, Pradnya D Patil, Nathan A Pennell
Journal of the National Comprehensive Cancer Network. 2022-08-01
Lectures
- Impact of invasive regional lymph node examination (IRLNE) and time to radiation on overall survival for patients with stage I NSCLC treated with SBRT- a NCDB analysis.2019 ASCO Annual Meeting - 6/1/2019
- Incidence and patterns of immune related adverse events (irAEs) during chemoimmunotherapy (ChemoIO) in patients with advanced nonsquamous NSCLC.2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
- Neutrophil to Lymphocyte Ratio Influences Impact of Steroids on Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Brain MetastasesApril 5th, 2021
- Artificial Intelligence Identifies Lung Cancer Patients at Risk of Harm Caused by ImmunotherapyFebruary 9th, 2021
- AI Technology Can Help Prevent Adverse Effect of Immunotherapy in Certain Lung Cancer PatientsFebruary 5th, 2021
- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: